AIDS: Assessing opportunities and challenges in HIV vaccine development in Asia

Despite the availability of antiretroviral therapy for HIV/AIDS, treatment alone will not curtail the HIV/AIDS pandemic. Thus, developing a safe, effective and affordable vaccine that can prevent HIV infection in uninfected people is the best chance at controlling and possibly eliminating the AIDS epidemic. At the upcoming World Vaccine Congress Asia 2013, Mr. Rutt Chuachoowong will be speaking on the topic entitled "AIDS: Assessing opportunities and challenges in HIV vaccine development in Asia". He will be giving an overview of the HIV epidemiology in Asia, and will be sharing on how to overcome difficulties of patient recruitment for ensuring ethical and effective clinical trials of HIV vaccine candidates as well as strategies to build robust clinical studies on regional population to obtain local market approval.

Mr. Rutt Chuachoowong is the Medical Director at Takeda, Thailand. He had previously worked as a Product Physician at Takeda, Thailand, a Disease Area Specialist at Britol-Myers Squibb Pharma, Thailand, and a Medical Director at Silom Community Clinic, Bangkok Christian Hospital and a Senior Medical Research Scientist at the HIV Clinical Research Team, Thailand MOPH.

World Vaccine Congress Asia 2013 will be held from 17-20 June 2013 at Grand Copthorne Waterfront Hotel, Singapore. Register here to catch Mr. Chuachoowong's talk on day two of the conference!

Leave a Reply

Your email address will not be published. Required fields are marked *